These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2547832)

  • 1. Biphasic forearm vascular responses to intraarterial arginine vasopressin.
    Suzuki S; Takeshita A; Imaizumi T; Hirooka Y; Yoshida M; Ando S; Nakamura M
    J Clin Invest; 1989 Aug; 84(2):427-34. PubMed ID: 2547832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.
    Hirsch AT; Dzau VJ; Majzoub JA; Creager MA
    J Clin Invest; 1989 Aug; 84(2):418-26. PubMed ID: 2527249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels.
    Tagawa T; Imaizumi T; Endo T; Shiramoto M; Hirooka Y; Ando S; Takeshita A
    J Clin Invest; 1993 Sep; 92(3):1483-90. PubMed ID: 8376600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V2 receptor-mediated vasodilation in healthy humans.
    Tagawa T; Imaizumi T; Shiramoto M; Endo T; Hironaga K; Takeshita A
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):387-92. PubMed ID: 7769802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
    Postma CT; Maessen SM; Thien T; Smits P
    Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous vascular response to vasopressin: radial artery versus forearm blood flow.
    Hayoz D; Weber R; Pechère A; Burnier M; Brunner HR
    J Hypertens; 1997 Jan; 15(1):35-41. PubMed ID: 9050968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vasopressin on the circulation and its baroreflex control in healthy men.
    Aylward PE; Floras JS; Leimbach WN; Abboud FM
    Circulation; 1986 Jun; 73(6):1145-54. PubMed ID: 3698249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
    van Lieburg AF; Knoers NV; Monnens LA; Smits P
    J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine vasopressin attenuates phenylephrine-induced forearm vasoconstriction in men.
    Harada S; Imaizumi T; Momohara M; Masaki H; Ando S; Takeshita A
    Clin Sci (Lond); 1991 Dec; 81(6):733-7. PubMed ID: 1662578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of OPC-21268, an orally effective vasopressin V1 receptor antagonist in humans.
    Imaizumi T; Harada S; Hirooka Y; Masaki H; Momohara M; Takeshita A
    Hypertension; 1992 Jul; 20(1):54-8. PubMed ID: 1319959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of isoproterenol-mediated vasodilatation in blacks.
    Lang CC; Stein CM; Brown RM; Deegan R; Nelson R; He HB; Wood M; Wood AJ
    N Engl J Med; 1995 Jul; 333(3):155-60. PubMed ID: 7791817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial vasopressin in the human forearm: pharmacodynamics and the role of nitric oxide.
    Affolter JT; McKee SP; Helmy A; Jones CR; Newby DE; Webb DJ
    Clin Pharmacol Ther; 2003 Jul; 74(1):9-16. PubMed ID: 12844130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilatation by angiotensin II of the rat femoral arterial bed in vivo via pressure/flow-induced release of nitric oxide and prostaglandins.
    Heinemann A; Wachter CH; Peskar BA; Holzer P
    Br J Pharmacol; 1997 Nov; 122(6):975-84. PubMed ID: 9401758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal vasoconstriction by vasopressin V1a receptors is modulated by nitric oxide, prostanoids, and superoxide but not the ADP ribosyl cyclase CD38.
    Moss NG; Kopple TE; Arendshorst WJ
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1143-54. PubMed ID: 24623148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans.
    Weber R; Pechère-Bertschi A; Hayoz D; Gerc V; Brouard R; Lahmy JP; Brunner HR; Burnier M
    Hypertension; 1997 Nov; 30(5):1121-7. PubMed ID: 9369265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha modulates arteriolar reactivity secondary to a change in intimal permeability.
    Matsuki T; Duling BR
    Microcirculation; 2000 Dec; 7(6 Pt 1):411-8. PubMed ID: 11142338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.
    Yared A; Kon V; Ichikawa I
    J Clin Invest; 1985 May; 75(5):1477-87. PubMed ID: 3998146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by prostaglandins of the renal vascular action of arginine vasopressin.
    Oliver JA; Sciacca RR; Le Cren G; Cannon PJ
    Prostaglandins; 1982 Nov; 24(5):641-56. PubMed ID: 6962466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.